GAIN THERAPEUTICS, INC Accumulated Other Comprehensive Income
GAIN THERAPEUTICS, INC (GANX) had Accumulated Other Comprehensive Income of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $996.95K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $776.87K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $563.22K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $996.95K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $776.87K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $563.22K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $584.08K 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$119.86K 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$247.55K 10-K · filed 2026-03-26 |
| 2024-09-30 | $242.81K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $12.46K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.86K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $247.24K 10-K · filed 2025-03-27 |
| 2023-09-30 | $90.66K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $134.32K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $96.31K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $35.63K 10-K · filed 2024-03-26 |
| 2022-09-30 | -$296.90K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$145.57K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$114.30K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$90.64K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$112.08K 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$164.12K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$156.86K 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$152.70K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |